Lymphopenia is a known predictor of mortality in cancer patients [33] and part of its detrimental effect on prognosis has to be found in the impairment of the CD8+ cytotoxic immune system branch, with a consequential reduction of the immune-mediated antitumour response [34]. This evidence concerns the gene CD8A and lymphopenia.